Ledger.Open graph →
SEC Form D · filed March 4, 2020

Wize Pharma, Inc

Offering
$7.5M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOD HASHARON, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mark Sieczkarek · Costa Mesa, CADirectorYossi Keret · Hod Hasharon, L3DirectorNoam Danenberg · Hod Hasharon, L3ExecOr Eisenberg · Hod Hasharon, L3ExecJospeh Zarzewsky · Hod Hasharon, L3DirectorMichael Belkin · Hod Hasharon, L3DirectorFranck Amouyal · Hod Hasharon, L3DirectorNoam Danenberg · Hod Hasharon, L3ExecOr Eisenberg · Hod Hasharon, L3ExecJospeh Zarzewsky · Hod Hasharon, L3DirectorMark Sieczkarek · Hayward, CADirectorMichael Belkin · Hod Hasharon, L3DirectorYossi Keret · Hod Hasharon, L3DirectorFranck Amouyal · Hod Hasharon, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Wize Pharma, Inc. — SEC Form D filing (2020) | Ledger